Form 4: Teladoc Health Officer Raman-Tangella Vidya Reports Stock Transactions

Vidya Raman-Tangella, Chief Medical Officer of Teladoc Health, reports the vesting and subsequent sale of shares to cover tax obligations.

Summary

• On August 30, 2024, Vidya Raman-Tangella, Chief Medical Officer of Teladoc Health, exercised performance stock units converting to 792 shares of common stock.
• On the same day, 2,325 restricted stock units vested and converted to common stock.
• On September 3, 2024, Ms. Raman-Tangella sold 1,114 shares of common stock at a price of $7.164 per share.
• The sale was to cover tax withholding obligations related to the vesting of the performance stock units and restricted stock units.
• Following these transactions, Ms. Raman-Tangella directly owns 34,133 shares of Teladoc Health common stock, 4,756 performance stock units, and 13,952 restricted stock units.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions by an officer. It doesn't inherently convey positive or negative sentiment about the company's performance.

Industry Context

This Form 4 filing is a routine disclosure related to insider transactions and provides transparency into the stock ownership of Teladoc Health's executives. It's a standard practice for publicly traded companies.

Stakeholder Impact

• The transactions have a minor impact on shareholders as they involve a relatively small number of shares being sold by an executive.

Key Dates